Laboratory research has always been at the forefront of scientific innovation, driving breakthroughs in medicine, materials science, and more. Recently, the integration of automation and artificial intelligence (AI) has begun to revolutionize how research is conducted, offering unprecedented
The intersection of biotechnology and artificial intelligence (AI) is poised to address the inefficiencies and ethical concerns plaguing the current drug development process. One of the most promising innovations in this field is the Bio-AI clinical prediction platform developed by Quris-AI, which
Cancer therapy has always been a challenging field, with the need to balance efficacy and minimize side effects. Traditional treatments often lack precision, leading to systemic toxicity and reduced patient quality of life. In recent years, the development of drug-based nanostructures has emerged
In recent developments, a collaborative research team led by the University of Arizona College of Medicine – Tucson has discovered groundbreaking potential for an FDA-approved osteoporosis drug in the treatment of a rare genetic heart disease. The heart condition in question is dilated c
Chordoma, a rare bone cancer affecting about one in a million people, has long been a medical enigma. Historically, the lack of understanding and effective treatments has rendered it untreatable. However, recent breakthroughs by Professor Paul Workman and his team offer new hope. This article
AI is revolutionizing precision and personalized oncology care by enabling more accurate diagnoses, predicting patient outcomes, and tailoring treatments to individual needs. Through advanced algorithms and machine learning, AI can analyze vast amounts of data, including medical records, genetic
